Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-100,000
Closed -$8.73M 107
2019
Q4
$8.73M Sell
100,000
-150,000
-60% -$12.8M 0.34% 50
2019
Q3
$18.6M Hold
250,000
0.74% 26
2019
Q2
$21.2M Buy
+250,000
New +$20.1M 0.86% 28
2018
Q2
Sell
-550,000
Closed -$45.8M 109
2018
Q1
$45.8M Buy
550,000
+300,000
+120% +$27M 0.57% 18
2017
Q4
$23.7M Buy
250,000
+100,000
+67% +$10.5M 0.36% 26
2017
Q3
$17.5M Sell
150,000
-50,000
-25% -$6.33M 0.3% 27
2017
Q2
$25.2M Buy
+200,000
New +$25.4M 0.44% 20
2017
Q1
Sell
-100,000
Closed -$10M 103
2016
Q4
$10M Hold
100,000
0.22% 36
2016
Q3
$9.43M Buy
+100,000
New +$8.43M 0.19% 37
2016
Q1
Sell
-50,000
Closed -$5.42M 70
2015
Q4
$5.42M Buy
+50,000
New +$5.58M 0.1% 63

Other funds holding INCY

Artal Group's INCY Position: Q2 2018 in Review

Artal Group sold out of Incyte (INCY) in Q2 2018, closing a stake of 300,000 shares — an estimated $25M sold.

Artal Group first reported a position in INCY in Q1 2014 and held it in 17 quarters. The position peaked at $65.2M in Q4 2016. 453 funds tracked by Wall St. Rank hold INCY as of Q2 2018.

  • Artal Group reported no remaining Incyte position as of Q2 2018 after selling out during the quarter.
  • Artal Group sold 300,000 Incyte shares in Q2 2018, an estimated $25M.
  • Artal Group first reported a position in Incyte in Q1 2014 and held it in 17 quarters.
  • Artal Group's Incyte position peaked at $65.2M in Q4 2016.
  • 453 funds tracked by Wall St. Rank held Incyte as of Q2 2018.

Based on Artal Group's 13F filing for Q2 2018, filed 10 Aug 2018.